Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are attending the U.S. Olympic and Paralympic Committee Team USA Medi…
Trump's Tariffs: Any Road to Relief? Donald Trump has a longstanding fixation with tariffs, once calling them the "greatest thing ever". T…
Trump Rejects Vice Presidential Run Donald Trump has ruled out running for vice president in the 2028 American election. Aboard Air…
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…
Can the Warriors Maximize Stephen Curry's Remaining Years? Stephen Curry remains an exceptional player, and his supporting cast has improv…
New Parking Initiative to Boost Waverley Town Centres Waverley Borough Council is trialing a new parking scheme, "Pay One, Stay Two", to e…
Swift Solar Deploys Perovskite Modules at DoD Cyber Exercise Swift Solar, a US solar technology company, has deployed perovskite solar tec…
Ericsson and Nokia Collaborate on 6G Video Research Nokia, Ericsson, and the Fraunhofer Heinrich Hertz Institute have presented a proof-of…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…